ridm@nrct.go.th   ระบบคลังข้อมูลงานวิจัยไทย   รายการโปรดที่คุณเลือกไว้

International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009

หน่วยงาน สถาบันวิจัยและให้คำปรึกษาแห่ง มหาวิทยาลัยธรรมศาสตร์


ชื่อเรื่อง : International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009
นักวิจัย : Rosenthal, Victor D. , Bijie, Hu , Maki, Dennis G. , Mehta, Yatin , Anucha Apisarnthanarak , Medeiros, Eduardo A. , Leblebicioglu, Hakan , Fisher, Dale , Alvarez-Moreno, Carlos , Khader, Ilham Abu , Del Rocio Gonzalez Martinez, Marisela , Cuellar, Luis E. , Navoa-Ng, Josephine Anne , Abouqal, Redouane , Guanche Garcell, Humberto , Mitrev, Zan , Pirez Garcia, Maria Catalina , Hamdi, Asma , Duenas, Lourdes , Cancel, Elsie , Gurskis, Vaidotas , Rasslan, Ossama , Ahmed, Altaf , Kanj, Souha S. , Ugalde, Olber Chavarría , Mapp, Trudell , Raka, Lul , Yuet Meng, Cheong , Thu, Le Thi Anh , Ghazal, Sameeh , Gikas, Achilleas , Narvaez, Leonardo Pazmino , Mejia, Nepomuceno , Hadjieva, Nassya , Gamar Elanbya, May Osman , Guzman Siritt, Maria Eugenia , Jayatilleke, Kushlani
คำค้น : Bacterial infections , Antibiotic resistance , Bloodstream infection , Catheter-associated urinary tract infection , Central line-associated bloodstream infection , Developing countries , Device-associated infection , Health care-associated infection , Hospital infection , Limited-resources countries , Low-income countries , Network , Nosocomial infection , Urinary tract infection , Ventilator-associated pneumonia , Ceftazidime , Meticillin
หน่วยงาน : สถาบันวิจัยและให้คำปรึกษาแห่ง มหาวิทยาลัยธรรมศาสตร์
ผู้ร่วมงาน : -
ปีพิมพ์ : 2555
อ้างอิง : American journal of infection control. 40,5 (2012) pp. 396-407 , 0196-6553 , http://dspace.library.tu.ac.th/handle/3517/6395
ที่มา : -
ความเชี่ยวชาญ : -
ความสัมพันธ์ : -
ขอบเขตของเนื้อหา : -
บทคัดย่อ/คำอธิบาย :

The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in 422 intensive care units (ICUs) of 36 countries in Latin America, Asia, Africa, and Europe are reported. During the 6-year study period, using Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system [NNIS]) definitions for device-associated health care-associated infections, we gathered prospective data from 313,008 patients hospitalized in the consortium's ICUs for an aggregate of 2,194,897 ICU bed-days. Despite the fact that the use of devices in the developing countries' ICUs was remarkably similar to that reported in US ICUs in the CDC's NHSN, rates of device-associated nosocomial infection were significantly higher in the ICUs of the INICC hospitals; the pooled rate of central line-associated bloodstream infection in the INICC ICUs of 6.8 per 1,000 central line-days was more than 3-fold higher than the 2.0 per 1,000 central line-days reported in comparable US ICUs. The overall rate of ventilator-associated pneumonia also was far higher (15.8 vs 3.3 per 1,000 ventilator-days), as was the rate of catheter-associated urinary tract infection (6.3 vs. 3.3 per 1,000 catheter-days). Notably, the frequencies of resistance of Pseudomonas aeruginosa isolates to imipenem (47.2% vs 23.0%), Klebsiella pneumoniae isolates to ceftazidime (76.3% vs 27.1%), Escherichia coli isolates to ceftazidime (66.7% vs 8.1%), Staphylococcus aureus isolates to methicillin (84.4% vs 56.8%), were also higher in the consortium's ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 7.3% (for catheter-associated urinary tract infection) to 15.2% (for ventilator-associated pneumonia). Copyright © 2012 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

บรรณานุกรม :